These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 22190262

  • 1. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
    Zaja F, Marin L, Chiozzotto M, Puglisi S, Volpetti S, Fanin R.
    Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262
    [Abstract] [Full Text] [Related]

  • 2. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C, Castaman G, Rodeghiero F.
    Haematologica; 1993 Mar; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [Abstract] [Full Text] [Related]

  • 3. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM, De Paula EV, Ozelo MC, Orsi FL, Fabri DR, Annichino-Bizzacchi JM.
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [Abstract] [Full Text] [Related]

  • 5. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J, Majluf-Cruz A, Montiel-Cervantes L, Esparza MG, Vela-Ojeda J, Mexican Hematology Study Group.
    Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
    Zaja F, Volpetti S, Chiozzotto M, Puglisi S, Isola M, Buttignol S, Fanin R.
    Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
    [Abstract] [Full Text] [Related]

  • 7. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE, Pamuk ON, Başlar Z, Ongören S, Soysal T, Ferhanoğlu B, Aydin Y, Ulkü B, Aktuğlu G, Akman N.
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [Abstract] [Full Text] [Related]

  • 8. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
    Zhou H, Fu R, Wang H, Zhou F, Li H, Zhou Z, Zhang L, Yang R.
    Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia.
    Zoghlami-Rintelen C, Weltermann A, Bittermann C, Kyrle PA, Pabinger I, Lechner K, Wenzl E.
    Ann Hematol; 2003 May; 82(5):290-4. PubMed ID: 12739064
    [Abstract] [Full Text] [Related]

  • 10. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results.
    Medeot M, Zaja F, Vianelli N, Battista M, Baccarani M, Patriarca F, Soldano F, Isola M, De Luca S, Fanin R.
    Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702
    [Abstract] [Full Text] [Related]

  • 11. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C, Reu FJ, Ho AD, Hensel M.
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
    Llamas P, Busto MJ, Díez JL, Cabrera R, Regidor C, Forés R, Sanjuán I, Briz M, Fernández MN.
    Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
    [Abstract] [Full Text] [Related]

  • 13. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients.
    Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A.
    Eur J Haematol; 2005 Oct; 75(4):328-31. PubMed ID: 16146539
    [Abstract] [Full Text] [Related]

  • 14. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
    Aleem A.
    Platelets; 2011 Oct; 22(1):1-7. PubMed ID: 20964585
    [Abstract] [Full Text] [Related]

  • 15. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia].
    Zhu YC, Wang W, Zhou YH, Wang XM, Wang X, Wang YL, Sun GZ, Hou M.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):163-7. PubMed ID: 21535953
    [Abstract] [Full Text] [Related]

  • 16. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH.
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [Abstract] [Full Text] [Related]

  • 17. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y, Karapinar TH, Oymak Y, Toret E, Demirag B, Ince D, Ozcan E, Moueminoglou N, Koker SA, Vergin C.
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [Abstract] [Full Text] [Related]

  • 18. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A.
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [Abstract] [Full Text] [Related]

  • 19. Low-dose rituximab in adult patients with primary immune thrombocytopenia.
    Zaja F, Vianelli N, Volpetti S, Battista ML, Defina M, Palmieri S, Bocchia M, Medeot M, De Luca S, Ferrara F, Isola M, Baccarani M, Fanin R.
    Eur J Haematol; 2010 Oct; 85(4):329-34. PubMed ID: 20546023
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of idiopathic thrombocytopenic purpura with danazol].
    Ruberto E, Espinola R.
    Sangre (Barc); 1995 Aug; 40(4):307-10. PubMed ID: 7482120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.